Keytruda who is owned by?

Who owns Keytruda (pembrolizumab)?

Keytruda is owned and marketed by Merck & Co., Inc., based in the United States. In the U.S., the company sells the drug under the Merck name; in other countries, it may be branded differently depending on local licensing and corporate structure.

Are there any co-marketers or licensing partners for Keytruda?

The drug is produced and commercialized by Merck, and any additional partners are typically tied to regional distribution, manufacturing, or specific sales arrangements rather than a separate “owner” of the product itself.

Who owns Merck & Co.?

Merck & Co. is a publicly traded company, so it is ultimately owned by its shareholders.

Sources

• [1] https://www.drugpatentwatch.com/patent/keytruda